期刊文献+

造血干细胞移植后侵袭性真菌感染的诊断和治疗进展 被引量:6

Current Approaches to Diagnosis and Treatment of Invasive Fungal Infection in HSCT Recipients——Review
下载PDF
导出
摘要 侵袭性真菌感染(invasive fungal infections,IFI)是造血干细胞移植(HSCT)后常见的严重并发症之一,以念珠菌感染和曲霉菌感染最为常见。由于免疫抑制剂的应用、清髓预处理、急性或慢性移植物抗宿主病(GVHD)、广谱抗生素的长期应用、巨细胞病毒(CMV)感染等因素,IFI呈逐渐增多的趋势。侵袭性霉菌感染(invasive mould infection)已成为造血干细胞移植后IFI发病率和死亡率增加的主要原因。IFI早期诊断方法包括临床检查、实验室检测和特征性影像学检查。目前伏立康唑是确诊IFI的一线治疗用药,唑类或两性霉素B联合棘白霉素类抗真菌药也显示出较好治疗效果,有希望成为一项未来的抗真菌治疗策略。本文就造血干细胞移植后IFI的早期临床诊断和治疗问题作一综述。在IFI早期诊断方面讨论了实验室诊断技术,包括GM试验,G试验和PCR技术等;在IFI预防和治疗方面讨论了预防治疗,经验治疗,优先治疗,确诊后治疗,联合治疗和免疫治疗等。 Invasive fungal infections (IFI) are a kind of the most severe complications after hematopoietic stem cell transplantation (HSCT), Candida and Aspergillus are common causes. Because of immunosuppressive therapy, ablative conditioning regimen, acute or chronic graft-versus-host disease, long-term treatment of broad-spectrum antibiotics and cytomegalovirus infection, IFI has increased in the past few years. Invasive mould infection is a major cause of morbidi- ty and mortality in HSCT recipients. Methods for early diagnosis of IFI include clinical and laboratory examinations, as well as characteristic radiography. Voriconazole is the first-line antifungal agent for prevention of LFI. Combination therapy of two antifungal compounds such as azoles or amphotericin B with echinocandins have shown a good effectiveness and may be a promising future strategy for antifungal treatment. In this review, the early diagnosis and treatment of IFI in HSCT recipients are summarized. As for early diagnosis of IFI, the laboratory diagnosis techniques such as GM test, G test and PCR techniques are discussed. As for prophylaxis and freatment of IFI, the prophylaxis treatemnt, empirical treatment, preemptive treatment, targeted treatment, combined treatment and immunologic treatment are discussed.
作者 邵青 沈定霞
出处 《中国实验血液学杂志》 CAS CSCD 2009年第6期1619-1623,共5页 Journal of Experimental Hematology
基金 北京市首都医学发展基金资助项目 编号20072040
关键词 侵袭性真菌感染 侵袭性霉菌感染 造血干细胞移植 invasive fungal infection invasive mould infection hematopoietic stem cell transplantation
  • 相关文献

共引文献556

同被引文献51

  • 1李军体,孟凡义,孙竞,徐兵,刘晓力.恶性血液病合并侵袭性真菌感染73例治疗分析[J].中国实用内科杂志,2006,26(3):376-378. 被引量:23
  • 2血液病/恶性肿瘤患者侵袭性真菌感染的诊断标准与治疗原则(修订版)[J].中华内科杂志,2007,46(7):607-610. 被引量:250
  • 3LehrnbecherT, Frank C, Engels K, et al. Trends in the post- mortem epidemiology of invasive fungal infections at a university hospital [J]. lnfect JT, 2010, 61 (3): 259-265. 被引量:1
  • 4Pagano L, Caira M, Valentini CG, et al. Current therapeutic ap- proaches to fungal in fections in immunoeompromisod hematological patients [J]. Blood Rev, 2010, 24 (2): 51-61. 被引量:1
  • 5Neofytos D,Lu K,Hatfield-Seung A,et al.Epidemiology,outcomes,and risk factors of invasive fungal infections in adult patients with acute myelogenous leukemia after induction chemotherapy.Diagn Microbiol Infect Dis,2013 ;75 (2):144-149. 被引量:1
  • 6Pierrakos C,Vincent JL.Sepsis biomarkers:a review.Crit Care,2010; 14(1):R15. 被引量:1
  • 7Vaschetto R,Protti A.Biomarkers of sepsis in long-term critically ill patients.Minerva Anestesiol,2010 ; 76 (10):771-772. 被引量:1
  • 8Hughes WT,Armstrong D,Bodey GP,et al.2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.Clin Infect Dis,2002;34(6):730-751. 被引量:1
  • 9Jeddi R,Ghédira H,Ben Amor R,et al.Risk factors of septic shock in patients with hematologic malignancies and Pseudomonas infections.Hematology,2011 ; 16 (3):160-165. 被引量:1
  • 10Meisner M,Reinhart K.Biomarkers in the critically ill patient:procalcitonin.Crit Care Clin,2011 ;27 (2):253-263. 被引量:1

引证文献6

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部